| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Articles |
Department of Molecular Biology (Y.Y., K.U., S.K.), The Tokyo Metropolitan Institute of Medical Science (Rinsho-ken), 3-18-22, Honkomagome Bunkyo-ku, Tokyo 113, Japan; Department of Chemistry (K.U., H.I.), Aoyama-Gakuin University, 6-16-1, Chitosedai, Setagaya-ku, Tokyo 157, Japan
Address all correspondence and requests for reprints to: Dr. Yukiko Yajima, Department of Molecular Biology, The Tokyo Metropolitan Institute of Medical Science (Rinsho-ken), 3-18-22, Honkomagome, Bunkyo-ku, Tokyo 113, Japan. E-mail: yajima{at}rinshoken.or.jp
Mastoparan has been reported to induce a wide variety of cellular
actions by activating GTP-binding proteins (G proteins) in various
cells. Here, we demonstrate that mastoparan is able to stimulate the
secretion of PRL from rat anterior pituitary tumor GH3
cells in dose- and time-dependent manners. Mastoparan had no effect on
the accumulation of intracellular cAMP; however, it induced a
rapid increase in the intracellular Ca2+ concentration in
GH3 cells. Extracellular Ca2+ was required for
mastoparan-induced PRL secretion, which was inhibited by nifedipine, an
L-type Ca2+ channel blocker. Incubation of
mastoparan with myo-[3H]inositol-labeled
GH3 cells also resulted in the increased formation of
inositol phosphates (InsPs) compared with control cells. Neomycin
sulfate and U73122, both phospholipase C inhibitors, suppressed
mastoparan-induced PRL secretion. Guanosine 5'-[ß-thio]diphosphate
(GDPßS) encapsulated in GH3 cells by reversible
electropermeabilization suppressed the response to mastoparan. However,
pretreatment with pertussis toxin had no effect on the stimulation of
PRL secretion by mastoparan, and both Mas7 (a highly active analogue of
mastoparan) and Mas17 (an inactive analogue) enhanced the secretion of
PRL to a similar level to that of mastoparan-induced GH3
cells. In contrast, the substance P-related peptide GPant-2A, a
Gq antagonist, inhibited mastoparan-induced PRL release,
whereas GPant-2, a Gi/o antagonist, did not in
electropermeabilized GH3 cells. Moreover, a specific
Gq/11 antibody against the carboxyl terminus of the
Gq/11
-subunit blocked the stimulatory effect of
mastoparan on secretion and mastoparan-stimulated InsPs production in
digitonin-permeabilized GH3 cells. These results indicate
that mastoparan induces the Ca2+-regulated secretion of PRL
from GH3 cells by activating Gq/11 and the
phospholipase C pathway.
This article has been cited by other articles:
![]() |
H. S. Kim, S. Yumkham, J. H. Choi, G. H. Son, K. Kim, S. H. Ryu, and P.-G. Suh Serotonin stimulates GnRH secretion through the c-Src-PLC {gamma}1 pathway in GT1-7 hypothalamic cells. J. Endocrinol., September 1, 2006; 190(3): 581 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lenglet, E. Louiset, C. Delarue, H. Vaudry, and V. Contesse Activation of 5-HT7 Receptor in Rat Glomerulosa Cells Is Associated with an Increase in Adenylyl Cyclase Activity and Calcium Influx through T-Type Calcium Channels Endocrinology, May 1, 2002; 143(5): 1748 - 1760. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |